Interrupt administration & stabilize infant's condition before treatment resumption in the event of bradycardia, reflux into the endotracheal tube, airway obstruction, cyanosis, dislodgement of endotracheal tube or hyperventilation. Not a substitute for neonatal intensive care. Patients w/ both intraventricular hemorrhage & periventricular leukomalacia. Carefully monitor oxygenation & lung compliance for modification of O
2 therapy & ventilatory support. Concomitant use w/ experimental therapies of RDS eg, high-frequency ventilation.